<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04759859</url>
  </required_header>
  <id_info>
    <org_study_id>1997246</org_study_id>
    <nct_id>NCT04759859</nct_id>
  </id_info>
  <brief_title>Neuropsychological Functioning and Cerebral Perfusion Post Carotid Endarterectomy</brief_title>
  <official_title>Relationship Between Neuropsychological Functioning and Cerebral Perfusion in Patients Undergoing Carotid Endarterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CAMC Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CAMC Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to investigate the relationship between neuropsychological functioning and&#xD;
      brain perfusion in patients undergoing carotid endarterectomy and control patients undergoing&#xD;
      other peripheral vascular procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Carotid endarterectomy (CEA) is a vascular surgical procedure that is aimed at reducing&#xD;
      accumulated cholesterol and fats in carotid arteries. While some research indicates that CEA&#xD;
      is associated with improvements in neuropsychological functioning, other studies have&#xD;
      identified deficits in neuropsychological functioning following CEA. The factors associated&#xD;
      with these different outcomes are unclear. Identification of the factors that mediate&#xD;
      post-CEA neuropsychological functioning outcomes may allow for the development of&#xD;
      interventions that would improve such outcomes. Recent research has identified a relationship&#xD;
      between post-CEA neuropsychological deficits, and cerebral blood flow in certain areas of the&#xD;
      brain, with some indication that brain cell loss following CEA may be a key factor. The&#xD;
      proposed study will explore changes in cerebral blood flow through the use of&#xD;
      diffusion-weighted magnetic resonance images (DW-MRI) to investigate the relationship between&#xD;
      neuropsychological functioning and brain perfusion in 70 CEA patients and to compare&#xD;
      neuropsychological functioning of the CEA patients to a control group of 30 patients&#xD;
      undergoing other peripheral vascular surgical procedures. Patients' neuropsychological&#xD;
      functioning will be assessed pre, post and six months after the CEA or peripheral vascular&#xD;
      surgery. Additionally DW-MRI will be assessed pre and post surgery for the patients&#xD;
      undergoing CEA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    logistical issues with coordinating the clinical and testing areas&#xD;
  </why_stopped>
  <start_date type="Anticipated">January 22, 2013</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>A battery of eight neuropsychological tests</measure>
    <time_frame>7 days before surgery, 1-7 days after surgery and 6 months after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diffusion Weighted Magnetic Resonance Imaging</measure>
    <time_frame>7 days before surgery, 1-7 days after surgery</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Short Form-36</measure>
    <time_frame>7 days before surgery, 1-7 days after surgery and 6 months follow-up</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Beck Depression Inventory II</measure>
    <time_frame>7 days before surgery, 1-7 days after surgery and 6 months after surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>State-Trait Anxiety Inventory</measure>
    <time_frame>7 days before surgery, 1-7 days after surgery and 6 months after surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>An 11-point Numeric Pain Intensity Scale</measure>
    <time_frame>7 days before surgery, 1-7 days after surgery and 6 months after surgery</time_frame>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Carotid Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>Carotid Endarterectomy (CEA)</arm_group_label>
    <description>70 participants undergoing CEA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other Peripheral Vascular Surgery</arm_group_label>
    <description>30 participants undergoing other peripheral vascular surgical procedures</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        70 patients undergoing elective carotid endarterectomy and 30 patients undergoing other&#xD;
        peripheral vascular surgical procedures&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing elective carotid endarterectomy or other peripheral vascular&#xD;
             surgical procedures.&#xD;
&#xD;
          -  Ages 40-90&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of Substance Use:&#xD;
&#xD;
             History of cocaine use within the past 12 months. Tetrahydrocannabinol use within the&#xD;
             past 12 months.&#xD;
&#xD;
          2. Conditions that affect brain MRI/contraindications for MRI:&#xD;
&#xD;
             Diagnosis of HIV. History of any traumatic brain injury. History or current diagnosis&#xD;
             with any form of brain tumor. Current normal pressure hydrocephalus. Patients with any&#xD;
             implanted metallic medical device, or non-removable metallic material in their body&#xD;
&#xD;
          3. Conditions that affect neuropsychological assessment:&#xD;
&#xD;
             Diagnosis with Attention Deficit/Hyperactivity Disorder. Current major depressive&#xD;
             episode. Current manic episode. Current psychotic episode. Diagnosis with any&#xD;
             developmental disorder. Diagnosis with any form of dementia (MMSE&lt;24). A score higher&#xD;
             than 3 on the Modified Rankin Scale indicating a major stroke.&#xD;
&#xD;
          4. General Contraindications:&#xD;
&#xD;
        Diagnosis with or history of any medical condition that, based on reasonable clinical&#xD;
        judgment, would clinically contraindicate the patient undergoing any of the study&#xD;
        procedures.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali AbuRahma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charleston Area Medical Center Vascular Center of Excellence</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charleston Area Medical Center Vascular Center of Excellence</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <study_first_submitted>November 27, 2013</study_first_submitted>
  <study_first_submitted_qc>February 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>February 15, 2021</last_update_submitted>
  <last_update_submitted_qc>February 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CAMC Health System</investigator_affiliation>
    <investigator_full_name>Ali AbuRahma</investigator_full_name>
    <investigator_title>Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>Carotid Endarterectomy</keyword>
  <keyword>Neurocognitive Functioning</keyword>
  <keyword>Cerebral Perfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

